GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » Equity-to-Asset

Neurologix (Neurologix) Equity-to-Asset : -1.75 (As of Jun. 2011)


View and export this data going back to . Start your Free Trial

What is Neurologix Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Neurologix's Total Stockholders Equity for the quarter that ended in Jun. 2011 was $-8.66 Mil. Neurologix's Total Assets for the quarter that ended in Jun. 2011 was $4.96 Mil.

The historical rank and industry rank for Neurologix's Equity-to-Asset or its related term are showing as below:

NRGXQ's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.58
* Ranked among companies with meaningful Equity-to-Asset only.

Neurologix Equity-to-Asset Historical Data

The historical data trend for Neurologix's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix Equity-to-Asset Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 0.94 0.96 0.49 -0.43

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.37 -1.02 -0.43 -0.87 -1.75

Competitive Comparison of Neurologix's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Neurologix's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurologix's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurologix's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Neurologix's Equity-to-Asset falls into.



Neurologix Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Neurologix's Equity to Asset Ratio for the fiscal year that ended in Dec. 2010 is calculated as

Equity to Asset (A: Dec. 2010 )=Total Stockholders Equity/Total Assets
=-4.16/9.677
=

Neurologix's Equity to Asset Ratio for the quarter that ended in Jun. 2011 is calculated as

Equity to Asset (Q: Jun. 2011 )=Total Stockholders Equity/Total Assets
=-8.664/4.963
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurologix  (GREY:NRGXQ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Neurologix Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Neurologix's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines